Conditions: Benign Prostatic Hyperplasia
Allocation:  | Intervention model: PARALLEL
Enrollment: 24
Healthy volunteers: no

Brief summary:
The purpose of this study is to investigate the pharmacokinetics of tadalafil in Japanese and non-Japanese men with Benign Prostatic Hyperplasia (BPH).

The safety of tadalafil will also be studied.

Detailed description:

Arms:
arm 1: 5 mg, administered orally, daily for 10 days

Interventions: intervention 1: Tadalafil
Intervention descriptions: intervention 1: 5 mg, administered orally, daily for 10 days

Protocol document: